[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "MAT2A",
            "9p21",
            "CDKN2A",
            "MTAP",
            "Solid Tumors",
            "PRMT5",
            "SAM",
            "Synthetic Lethality",
            "Inhibitor",
            "MTAP deletion",
            "CDKN2A deletion",
            "MAT2A Inhibitor",
            "Advanced solid tumors",
            "Lung Cancer",
            "Pancreatic or Pancreas Cancer",
            "Bladder Cancer",
            "Renal Cancer",
            "Mesothelioma",
            "Esophageal Cancer",
            "Head and Neck Squamous Cell Carcinoma",
            "Gastric Cancer",
            "Breast cancer",
            "Melanoma",
            "Cholangiocarcinoma",
            "Squamous",
            "NSCLC",
            "SCCHN",
            "Urothelial Cancer",
            "Non small cell",
            "Docetaxel",
            "Paclitaxel",
            "Pemetrexed"
        ],
        "dcp_id": null,
        "interventional_model": "Parallel",
        "lead_org": "IDEAYA Biosciences",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Participant must be at least 18 years of age"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Advanced or metastatic solid tumor that has progressed on at least one prior line of treatment or is intolerant to additional effective standard therapy"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Have evidence of homozygous loss of MTAP or MTAP deletion"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Willing to undergo paired fresh biopsy (pre- and post-treatment) procedure. Exceptions may be made for feasibility and safety concerns"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Measurable disease"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "ECOG performance status <= 1 or 2 after discussion with medical monitor"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Adequate organ function"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Able to swallow and retain orally administered study treatment"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Recovery from acute effects of prior therapy"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Able to comply with contraceptive/barrier requirements"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 10,
                    "description": "Known symptomatic brain metastases"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 11,
                    "description": "Known primary CNS malignancy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 12,
                    "description": "Current active liver or biliary disease"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 13,
                    "description": "Impairment of gastrointestinal (GI) function"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 14,
                    "description": "Active uncontrolled infection"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "Clinically significant cardiac abnormalities"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "Previous treatment with a MAT2A inhibitor and / or PRMT inhibitor"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "Systemic anti-cancer therapy or major surgery within 4 weeks prior to study entry"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "Radiation therapy within 2 weeks prior to study entry"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "Prior irradiation to >25% of the bone marrow"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "Current use or anticipated need for food or drugs that are known strong CYP3A4/5 inhibitors or inducers"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Currently receiving another investigational study drug."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "Known or suspected hypersensitivity to IDE397/excipients or components"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": null,
        "official_title": "An Open Label, Phase 1, Treatment Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of IDE397 (MAT2A Inhibitor) In Adult Participants With Advanced Solid Tumors",
        "_phase_sort_order": 4,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "21 days following the first dose of IDE397",
                "name": "Dose-limiting Toxicities (DLTs) of IDE397",
                "description": "Incidence of DLTs of IDE397 will be determined",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "21 - 28 days following the first dose of IDE397",
                "name": "Dose-limiting Toxicities (DLTs) of IDE397 in combination with either docetaxel, paclitaxel, gemcitabine and nab-paclitaxel or pemetrexed",
                "description": "Incidence of DLTs of IDE397 in a combination setting will be determined",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Drug interaction between IDE397 and docetaxel or paclitaxel, nab-paclitaxel and gemcitabine and pemetrexed",
                "description": "Pharmacokinetics of docetaxel or paclitaxel, gemcitabine/nab-paclitaxel and pemetrexed.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Efficacy of IDE397 administered as a single agent and in combination with docetaxel, paclitaxel, gemcitabine and nab-paclitaxel and pemetrexed",
                "description": "Objective response rate and duration of response will be assessed by Blinded Imaging Committee Review using the Response Evaluation Criteria in Solid Tumors (RECIST v1.1)",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Maximum Tolerated Dose (MTD) and/or Recommended Phase 2 Dose (RP2D) of IDE397",
                "description": "MTD and RP2D of IDE397 will be determined",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Maximum Tolerated Dose (MTD) and/or Recommended Phase 2 Dose (RP2D) of IDE397 in combination with either docetaxel, paclitaxel, gemcitabine and nab-paclitaxel or pemetrexed",
                "description": "MTD and RP2D of IDE397 in a combination setting will be determined",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Objective Response Rate (ORR) and Duration of Response (DoR)",
                "description": "To evaluate preliminary anti-tumor activity of IDE397 in combination expansion arms",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Pharmacodynamic effect of IDE397 as a single agent and in combination with either docetaxel, paclitaxel, gemcitabine and nab-paclitaxel and pemetrexed",
                "description": "Changes in the levels of MAT2A pathway and PRMT5 pathway will be determined",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Plasma Pharmacokinetics of IDE397 and metabolite",
                "description": "Pharmacokinetics of IDE397 and metabolite following single and multiple oral administration as a single agent and in combination with either docetaxel, paclitaxel, gemcitabine and nab-paclitaxel or pemetrexed will be determined",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Preliminary anti-tumor activity in IDE397 escalation and combination escalation arms",
                "description": "Objective response rate and duration of response will be assessed using the Response Evaluation Criteria in Solid Tumors (RECIST v1.1)",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 8,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04794699",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "MTAP",
                    "Methylthioadenosine Phosphorylase Gene"
                ],
                "nci_thesaurus_concept_id": "C103994",
                "name": "MTAP Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C26147",
                    "C25870",
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C26147"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Chromosomal, Gene, or Protein Abnormality",
                    "Cytogenetic or Molecular Genetic Abnormality",
                    "Genetic Abnormality",
                    "MOLECULAR_ABNORMALITY",
                    "Molecular Alteration"
                ],
                "nci_thesaurus_concept_id": "C3910",
                "name": "Molecular Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Absent",
                    "LOST",
                    "Loss of Expression",
                    "Negative",
                    "Not Expressed"
                ],
                "nci_thesaurus_concept_id": "C165233",
                "name": "Expression Negative",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C35681"
                ],
                "parents": [
                    "C35681"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36327",
                "name": "Gene Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C97926",
                    "C36391",
                    "C3910"
                ],
                "parents": [
                    "C36391"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Gene Deletion Mutation",
                    "Transcript Ablation"
                ],
                "nci_thesaurus_concept_id": "C16606",
                "name": "Gene Deletion",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C36391",
                    "C45576",
                    "C36327",
                    "C19296",
                    "C2950",
                    "C3910",
                    "C36541",
                    "C133155",
                    "C97926",
                    "C9484"
                ],
                "parents": [
                    "C133155",
                    "C19296"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Negative"
                ],
                "nci_thesaurus_concept_id": "C35681",
                "name": "Negative Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Partial Monosomy",
                    "del"
                ],
                "nci_thesaurus_concept_id": "C9484",
                "name": "Chromosomal Deletion",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C2950",
                    "C3910",
                    "C36541"
                ],
                "parents": [
                    "C36541"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Chromosomal Rearrangements",
                    "Rearrangement",
                    "Structural Chromosomal Abnormality",
                    "Structural Chromosome Aberration",
                    "Structural Chromosome Anomalies"
                ],
                "nci_thesaurus_concept_id": "C36541",
                "name": "Chromosomal Rearrangement",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C2950",
                    "C3910"
                ],
                "parents": [
                    "C2950"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Aberrant Chromosome 9",
                    "Chromosome 9 Aberration"
                ],
                "nci_thesaurus_concept_id": "C180942",
                "name": "Chromosome 9 Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C3910",
                    "C2950"
                ],
                "parents": [
                    "C2950"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genetic Alteration",
                    "Genetic Change",
                    "Mutated",
                    "Mutation"
                ],
                "nci_thesaurus_concept_id": "C45576",
                "name": "Mutation Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C36391",
                    "C3910",
                    "C97926"
                ],
                "parents": [
                    "C36391"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Anomaly",
                    "DNA Sequence Variation",
                    "Genetic Abnormality",
                    "Genetic Alteration",
                    "Genetic Anomaly",
                    "Molecular Abnormality",
                    "Molecular Anomaly",
                    "Molecular Genetic Abnormality",
                    "Molecular Genetic Anomaly"
                ],
                "nci_thesaurus_concept_id": "C36391",
                "name": "Molecular Genetic Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C97926",
                    "C3910"
                ],
                "parents": [
                    "C97926"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "5'-Methylthioadenosine Phosphorylase Negative",
                    "MTA Phosphorylase Negative",
                    "MTAP Deficiency",
                    "MTAP Deficient",
                    "MTAP Loss",
                    "MTAP Null",
                    "MTAPase Negative",
                    "Methylthioadenosine Phosphorylase Loss",
                    "Methylthioadenosine Phosphorylase Negative",
                    "Methylthioadenosine Phosphorylase Null",
                    "S-Methyl-5'-Thioadenosine Phosphorylase Loss",
                    "S-Methyl-5'-Thioadenosine Phosphorylase Negative"
                ],
                "nci_thesaurus_concept_id": "C156051",
                "name": "MTAP Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C103994",
                    "C21281",
                    "C26147",
                    "C35681",
                    "C16612",
                    "C77140",
                    "C3367",
                    "C25870",
                    "C165233"
                ],
                "parents": [
                    "C103994",
                    "C165233"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Aberrant Chromosome",
                    "Chromosomal Aberration",
                    "Chromosomal Abnormalities",
                    "Chromosomal Abnormality",
                    "Chromosomal Alterations",
                    "Chromosome Aberration",
                    "Chromosome Abnormality",
                    "Chromosome Alterations",
                    "Chromosome Anomalies",
                    "Cytogenetic Aberration",
                    "Cytogenetic Analysis Abnormality Type",
                    "Genomic Structural Variation"
                ],
                "nci_thesaurus_concept_id": "C2950",
                "name": "Cytogenetic Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C3910"
                ],
                "parents": [
                    "C3910"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "MSAP Gene Deletion",
                    "MTAP Deletion",
                    "Methylthioadenosine Phosphorylase Gene Deletion"
                ],
                "nci_thesaurus_concept_id": "C177782",
                "name": "MTAP Gene Deletion",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C2950",
                    "C180942",
                    "C21281",
                    "C3910",
                    "C36391",
                    "C133155",
                    "C45576",
                    "C16606",
                    "C97926",
                    "C36541",
                    "C16612",
                    "C36327",
                    "C9484",
                    "C25870",
                    "C103994",
                    "C26147",
                    "C19296"
                ],
                "parents": [
                    "C103994",
                    "C16606",
                    "C180942"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "VARIANT_TYPE",
                    "molecular consequence",
                    "molecular_consequence"
                ],
                "nci_thesaurus_concept_id": "C97926",
                "name": "Molecular Sequence Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C3910"
                ],
                "parents": [
                    "C3910"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Abnormal Gene Rearrangement",
                    "Abnormal Rearrangement",
                    "Gene Rearrangement"
                ],
                "nci_thesaurus_concept_id": "C133155",
                "name": "Gene Rearrangement Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C36391",
                    "C36327",
                    "C2950",
                    "C3910",
                    "C36541",
                    "C97926"
                ],
                "parents": [
                    "C36327",
                    "C36541"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Deletion",
                    "Deletion Abnormality",
                    "Mutation, Deletion",
                    "del"
                ],
                "nci_thesaurus_concept_id": "C19296",
                "name": "Deletion Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C36391",
                    "C45576",
                    "C2950",
                    "C9484",
                    "C3910",
                    "C36541",
                    "C97926"
                ],
                "parents": [
                    "C45576",
                    "C9484"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C26147",
                "name": "Glycosyltransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2021-03-15",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Malignant Solid Neoplasm",
                    "Metastatic Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Advanced Solid Tumor",
                    "Advanced Solid Neoplasm",
                    "Advanced Non-Hematologic Malignancy",
                    "Advanced Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C129707",
                "name": "Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9270",
                    "C127155"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Neoplasm",
                    "Solid Tumour",
                    "Solid tumor, NOS"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "IDE397-001",
        "active_sites_count": 7,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Inhibitor Drug",
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Mitotic Inhibitor Agents",
                            "Mitosis Inhibitor Drugs",
                            "Mitosis Inhibitors",
                            "Mitotic Inhibitors",
                            "Antimitotic Drugs",
                            "Mitotic Inhibitor Drugs",
                            "Antimitotics",
                            "Microtubular Function Inhibitors",
                            "Mitosis Inhibitor Agents"
                        ],
                        "nci_thesaurus_concept_id": "C273",
                        "name": "Antimitotic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C186664"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Anzatax",
                            "Bristaxol",
                            "Asotax",
                            "Taxol Konzentrat",
                            "Praxel"
                        ],
                        "nci_thesaurus_concept_id": "C1411",
                        "name": "Paclitaxel",
                        "description": "A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity.  Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division.  This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C67437",
                            "C1490"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Protein Antagonist",
                            "Anti-cancer Protein Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Cytotoxic Chemotherapy Agent",
                            "Antineoplastic Cytotoxic Agent",
                            "Cytotoxic Antineoplastic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C186664",
                        "name": "Cytotoxic Chemotherapeutic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Tubulin Binding Agents"
                        ],
                        "nci_thesaurus_concept_id": "C25974",
                        "name": "Tubulin Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C273"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antimetabolites"
                        ],
                        "nci_thesaurus_concept_id": "C272",
                        "name": "Antimetabolite",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C186664"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastics",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs",
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Anti-Tumor Agents",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Anti-Tumor Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Lipids"
                        ],
                        "nci_thesaurus_concept_id": "C616",
                        "name": "Lipid",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Taxotere Injection Concentrate",
                            "Taxotere",
                            "Docecad"
                        ],
                        "nci_thesaurus_concept_id": "C1526",
                        "name": "Docetaxel",
                        "description": "A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree Taxus baccata.  Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death.  This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response.  Docetaxel has been studied for use as a radiation-sensitizing agent. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1490",
                            "C67437"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1557",
                        "name": "Pyrimidine Antagonist",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C272"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Abraxane"
                        ],
                        "nci_thesaurus_concept_id": "C2688",
                        "name": "Nab-paclitaxel",
                        "description": "A Cremophor EL-free, albumin-stabilized nanoparticle formulation of the natural taxane paclitaxel with antineoplastic activity. Paclitaxel binds to and stabilizes microtubules, preventing their depolymerization and so inhibiting cellular motility, mitosis, and replication. This formulation solubilizes paclitaxel without the use of the solvent Cremophor, thereby permitting the administration of larger doses of paclitaxel while avoiding the toxic effects associated with Cremophor. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C61078"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1913",
                        "name": "Drug or Chemical by Structure",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxane-Site Binding Agent"
                        ],
                        "nci_thesaurus_concept_id": "C67437",
                        "name": "Taxane-Pocket Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C25974"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals",
                            "Drug",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C66876",
                        "name": "Gemcitabine",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1557",
                            "C2150"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2150",
                        "name": "Ribonucleotide Reductase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hydrocarbons"
                        ],
                        "nci_thesaurus_concept_id": "C552",
                        "name": "Hydrocarbon",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C718",
                        "name": "Organic Chemical",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1913"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C153180",
                        "name": "MAT2A Inhibitor AG-270",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129825"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxanes"
                        ],
                        "nci_thesaurus_concept_id": "C1490",
                        "name": "Taxane Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C860"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Terpenes"
                        ],
                        "nci_thesaurus_concept_id": "C860",
                        "name": "Terpene Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C552",
                            "C616"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C61078",
                        "name": "Paclitaxel Preparation",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C67437"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Part 1: Dose Escalation Monotherapy (Solid Tumors)",
                "description": null,
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Part 2: Monotherapy Dose Expansion (NSCLC, Esophagogastric and Solid Tumors)",
                "description": null,
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Part 3: Combination Dose Escalation with docetaxel (NSCLC) or paclitaxel (Solid tumors)",
                "description": null,
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Part 4: Combination Dose Expansion with docetaxel (NSCLC) or paclitaxel (Esophagogastric)",
                "description": null,
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Part 5: Combination Dose Escalation with gemcitabine and nab-paclitaxel (Pancreatic)",
                "description": null,
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Part 6: Combination Dose Expansion with gemcitabine and nab-paclitaxel (Pancreatic)",
                "description": null,
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Part 7: Combination Dose Escalation with pemetrexed (Solid Tumors)",
                "description": null,
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Part 8: Combination Dose Expansion with pemetrexed (Solid Tumors)",
                "description": null,
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2021-06345",
        "why_study_stopped": null,
        "brief_summary": "This is a Phase 1, open-label, multicenter, dose escalation and expansion study of the\r\n      safety, PK, PD, and anti-tumor activity of IDE397 as a single agent and in combination with\r\n      docetaxel, paclitaxel, gemcitabine/nab-paclitaxel and pemetrexed in adult patients with\r\n      selected advanced or metastatic MTAP-deleted advanced solid tumors who are unresponsive to\r\n      standard of care therapy or for whom no curative therapy is available. IDE397 is a small\r\n      molecule inhibitor of methionine adenosyltransferase 2 alpha (MAT2A).",
        "brief_title": "Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion",
        "status_history": [
            {
                "status_date": "2021-03-15T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 382,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 0,
        "start_date": "2021-04-14",
        "record_verification_date": "2022-12-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": null,
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2024-06-30",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]